Schedule 13D ownership disclosure

China SXT Pharmaceuticals, Inc.

Security class unavailable · CUSIP: G2161P108

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
37.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-008588
Form type
SC 13D
Filer
China SXT Pharmaceuticals, Inc.
CIK
CIK 1723980
Filed
Feb 15, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub